SUMMARY Two families with familial exudative vitreoretinopathy were studied in which platelet aggregation defects were found in all the affected members. The major defect observed was absent platelet aggregation with arachidonic acid. In addition platelet aggregation with collagen and adrenaline was reduced in one severely affected member. The implication of the platelet aggregation defect in the pathogenesis of this retinal vascular disorder is discussed.
Familial exudative vitreoretinopathy (FEVR) was first described by Criswick and Schepens in 1969.' Later Gow and Oliver established that the condition was inherited as an autosomal dominant trait. 2 The clinical features of this disease closely resemble those of retrolental fibroplasia. l2 The early changes consist of abrupt termination of the retinal blood vessels immediately beyond the equator, extensive areas of capillary closure anterior to the terminatioan of the retinal vessels, and development of retinal neovascularisation at the junction of the retinal vessels and the capillary free zone.2-Vitreous haemorrhage is often the presenting complaint.
The late changes consist of an elevated fibrovascular scar usually in the temporal periphery, dragging of the optic disc and macula, and the development of traction and rhegmatogenous retinal detachment. l 24 Recently Brockhurst et al. have described histopathological findings of a prominent vitreous membrane posterior to the ora serrata in the advanced stages of the disorder. 5 In this study 2 families with FEVR are described in which associated platelet aggregation defects in the affected members of the family were also demonstrated. The implications of this haematological abnormality in the pathogenesis of retinal neovascularisation are discussed.
Materials and methods
Two families with FEVR have been studied. The pedigrees of these families are portrayed in Fig. 1 .
Family I consists of a sister (family IA), her brother (family IB) and their respective children. In family IA none of the members had any obvious clinical or fluorescein angiographic evidence of the disease, though fluorescein angiographic studies on the sister, which were examined by 2 other independent observers, were equivocal. In family IB the brother and 4 of his children were affected. In family II the father and his only son had the disorder.
Typical fundus changes of FEVR are shown in Fig.  2 graphic appearance of the retinal vascular abnormalities observed in the left and right eye respectively of patient IB4. Haematological studies were carried out in all members of the 2 families. These included plasma viscosity, haematocrit, platelet count, and platelet aggregation tests. The platelet aggregation studies consisted of platelet aggregation with 15 mM and 0-75 mM arachidonic acid, 1 ,ug adrenaline, high (4 ,ug) and low (1 ug) dose collagen, ADP and 1-5 mg ristocetin. The haematological investigation was done 'blind' with respect to the ophthalmological status of the patients. 0-75 mM arachidonic acid was used only when results of platelet aggregation with 1-5 mM arachidonic acid were normal. None of the patients had taken aspirin or other antiplatelet drugs before the tests.
Results
The results of platelet aggregation studies are given in Tables 1, 2 , and 3. Platelet aggregation with 1-5 mM arachidonic acid was absent in all the affected members in family LB (Table 1 ). Platelet aggregation with 1 ,ug collagen and 1 ,g adrenaline was also Familial exudative vitreoretinopathy associated with familial thrombocytopathy reduced in one of the affected children who had very severe retinal disease. All the other platelet aggregation studies were normal. In family IA (Table  2) platelet aggregation with 1.5 mM arachidonic acid was absent on one occasion and normal on another occasion in the mother and absent on 2 occasions in one of her sons. In the latter case platelet aggregation with 1 ,ug collagen was also reduced. Platelet aggregation with all the other reagents were normal. In family II (Table 3) platelet aggregation with 1-5 mM arachidonic acid was normal, but with 075 mM arachidonic acid platelet aggregation was absent in the 2 affected members of the family. All other platelet aggregation studies were normal in family II. All other haematological studies performed in these 2 families were normal.
Discussion
FEVR is a disorder in which peripheral retinal obliteration of varying severity is inherited as an autosomal dominant condition. The disease may be inadequate retinal vasotonia would result, which would fail to protect immature retinal blood vessels at birth, when normally blood oxygen tension and blood pressure suddenly rise. It is therefore important to determine whether or not such a deficiency of thromboxane A2 production as a consequence of the defective arachidonic acid metabolism exists in FEVR. This is currently being undertaken in our laboratory.
The significance of reduced platelet aggregation with 1 Ag collagen and 1 ug adrenaline in one member of family IA who had the most severe disease is unknown. In fact whether any of the platelet aggregation defects have a definite role to play in the pathogenesis of this disorder requires further clarification. Further families with FEVR need to be studied to establish whether or not the thrombocytopathy exists in constant association with the ophthalmic disorder. 
